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IVC reﬂuxAbstract Purpose: To evaluate the accuracy of computed tomography pulmonary angiography
(CTPA) parameters, for predicting short-term mortality in patients with acute pulmonary embolism
(PE).
Materials and methods: Thirty-two patients with proven PE had CT pulmonary angiography were
included in the study. The clot burden using the Qanadli score (QS), and the right ventricular dys-
function (RVD) parameters were assessed on CT by calculating right ventricular/left ventricular
(RV/LV) diameter ratios, interventricular septum abnormality, inferior vena cava contrast reﬂux,
azygous vein and superior vena cava measures. Contrast density in pulmonary artery and descend-
ing aorta was evaluated for all patients. Patients were followed up for 30 days and then classiﬁed as
survivors or non survivors.
Results: Thirty-two patients were included in the study, 23 (71.8%) of them were classiﬁed as sur-
vivors, and the other nine (28.1%) patients died within the ﬁrst month (non survivors). There was a
positive, but weak correlation between the Qanadli score and the short term mortality
(P value = 0.05). There was a statistically signiﬁcant relationship between the RV/LV ratio and
PE-related mortality, with a P value < 0.001. Also, there was a good correlation between degree
of IVC reﬂux and PE outcome (P< 0.001). The PA/AO diameter ratio, SVC diameter and azygous
vein diameter showed no statistically signiﬁcant difference between survivors and non survivors.
Conclusions: CTPA ﬁndings that may predict short term mortality are the high grades of inferior
vena cava reﬂux, RV/LV diameter ratio more than 1.2, and clot burden >18 according to the
Qanadli score and to a lesser degree the interventricular septum abnormality.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
Open access under CC BY-NC-ND license.
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Pulmonary embolism (PE) is a common and potentially fatal
cardiovascular disorder. The short-term mortality of PE varies
widely, ranging from less than 1% in hemodynamically stable
patients to over 90% in patients who present with cardiorespi-
ratory arrest (1).
Risk stratiﬁcation for patients with acute pulmonary embo-
lism (PE) is important to establish appropriate treatment and
management (2). Computed tomographic (CT) pulmonary
angiography has progressively been established as the frontline
imaging modality for the diagnosis of PE, replacing ventila-
tion-perfusion lung scintigraphy and pulmonary angiography
(3–5).
Several investigators have attempted to determine prognosis
from ﬁndings by computed tomography (CT). Authors of sev-
eral retrospective studies have suggested right sided heart strain
and embolic burden at CT as prognostic parameters (6,7).
The presence, location, and degree of obstruction of arterial
clots can be scored according to four different scoring systems
as proposed by Miller et al. (8), Walsh et al. (9), Qanadli et al.
(10), and Mastora et al. (11).
Acute PE increases the pressure of the pulmonary arterial
system and right ventricle (RV) resulting in RV dysfunction,
which may progress to right heart failure and circulatory col-
lapse (12,13). Patients with RV dysfunction have a higher mor-
tality rate than those without, even if they are initially
hemodynamically stable (13,14). Thus, the presence of RV dys-
function is a marker for adverse clinical outcome in patients
with acute PE (13–15).
The purpose of this study was to assess the prognostic value
of different parameters at multi-detector CT pulmonary angi-
ography in prediction of short term mortality in patients with
acute pulmonary embolism.2. Materials and methods
2.1. Patients
From December 2012 through October 2013, thirty-two
patients with proven pulmonary embolism (PE) were included
in the study. They had been followed up for 30 days and then
classiﬁed into survivors and non survivors. Only the CT with
acute PE at initial presentation was included. History and
physical emergency room notes, discharge summaries, and
progress notes were retrieved for each patient. Information
such as patient demographics (age, sex, and race), preexisting
co-morbidities, and discharge disposition was obtained.
Short-term death was deﬁned as death within 30 days (16).
Patients who could not be followed up for 30 days and patients
with major health problem that may affect survival (massive
myocardial infarction, cerebral infarction/hemorrhage, and
renal failure, etc.) were excluded from the study.
2.2. Pulmonary CTA
All scans were obtained using a commercially available
16-MDCT scanner (Somatom emotion 16, Siemens Medical
Solutions). Patients were examined in a supine position with
both arms extended above the head. A frontal scout viewwas acquired at 120 kVp and 50 mA. The angiography scan
was obtained in a caudocranial direction during a single inspi-
ratory breath-hold. The scan volume ranged from the level of
the right diaphragm to a level just above the aortic arch. A
standard collimation of 0.75 mm was used with a gantry rota-
tion speed of 0.5 s and a pitch factor of 1.1. Patients were
scanned with a kilovoltage of 100 kVp and a tube current level
of 200 mA (100 mAs) as the reference value.
Vessel opaciﬁcation was provided by intravenous adminis-
tration of 125 ml of ioversol (Optiray 350; Tyco Health/Mal-
linckrodt, St. Louis, MO) at a rate of 4–5 ml/s.
Injections were given automatically using a commercially
available injector (Injektron CT2, Medtron). Individual con-
trast optimization was based on bolus tracking (CARE Bolus,
Siemens) in the right ventricle using a trigger level of 100 H.
For measuring early contrast enhancement, a series of dynamic
monitoring scans was obtained at 2-s intervals using a low-
dose protocol (100 kVp; 20 mAs; slice thickness, 4.5 mm).
Bolus tracking was started 4 s after injection of the contrast
agent had started. Furthermore, an additional delay of 7 s
was added after bolus tracking before diagnostic pulmonary
CTA.
For further postprocessing, thin-slice reconstruction was
performed with a slice thickness of 1 mm, an increment of
0.7 mm. Final image analysis was performed on axial images
and on coronal maximum intensity projections (MIPs) with
slice thicknesses of 3 and 6 mm, respectively.
2.3. Image analysis
2.3.1. Clot burden
Current study quantiﬁed the vascular obstruction index (i.e.,
the percentage of vascular obstruction of the pulmonary arte-
rial tree caused by PE) by using the scoring system of Qanadli
et al. (10). In brief, this index is deﬁned as the number of seg-
mental artery branches that are blocked and corrected by a
factor of one for partial blockage or a factor of two for com-
pletely obstructive PE. With this scoring system, the highest
possible score is 40 (thrombus completely obstructing the pul-
monary trunk), which corresponds to a 100% obstruction
index (Table 1).
2.3.2. CT signs of right heart dysfunction
CT signs used to assess function of the right heart included the
ratio of right ventricle diameter to left ventricle diameter
(RV/LV ratio), ratio of main pulmonary artery diameter to
ascending aorta diameter (PA/AO ratio), superior vena cava
diameter and interventricular septum morphology. Diameters
(minor axes) of the right and left ventricles were measured
on the axial CT image of the heart at their widest point
(Fig. 1) (usually the image showing the atrioventricular valves)
between the inner surface of the free wall and the surface of the
interventricular septum (17). The RV/LV ratio was calculated.
The diameters of the main pulmonary artery and the ascending
aorta were measured on the transverse image at which the right
pulmonary artery is in contiguity with the main pulmonary
artery (7). The PA/AO ratio was calculated. The diameters
of the superior vena cava and azygos vein were measured on
the transverse CT image where the azygos vein reaches the
superior vena cava (17). Morphology of interventricular sep-
tum was considered normal (Fig. 2c) (convex toward the right
Table 1 The Qanadli score adapted from Qanadli et al. (10).
No. of arteries assessed Score Maximum score
10 segmental arteries
in each lung (n= 20)
0 – No thrombus observed 40
1 – Partial occlusion
2 – Total occlusion
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cle) (17).
2.3.3. IVC reﬂux
The severity of reﬂux of contrast medium into the IVC or
hepatic veins was graded using axial images into six categories
according to a previously published scale (18): (1) no reﬂux
into IVC; (2) trace of reﬂux into IVC only; (3) reﬂux into
IVC but not hepatic veins; (4) reﬂux into IVC with opaciﬁca-
tion of proximal hepatic veins; (5) reﬂux into IVC with opac-
iﬁcation of hepatic veins down to the mid-portion of the
liver; and (6) reﬂux into IVC with opaciﬁcation of distal hepa-
tic veins.
2.3.4. Pulmonary artery and aortic enhancement
For the ratio of the descending aorta enhancement to main
pulmonary artery enhancement, Hounsﬁeld unit (HU) of pul-(b(a)
(c)
Fig. 1 CTPA of a female patient aged 45 years. (a) Large thrombus
>1.4, with ﬂattening of the interventricular septum. (c) Signiﬁcant reﬂ
the 6th day.monary artery was measured at the widest area as possible of
main pulmonary artery on a trans-axial CT image from where
the main pulmonary artery branches to the left and the right
pulmonary arteries, and the Hounsﬁeld unit (HU) of the
descending aorta was measured from the same level.
2.3.5. Statistical analysis
Results are expressed as the mean ± standard deviation for
data distributed normally. Baseline characteristics and imaging
parameters were analyzed by ANOVA and chi-squared test. A
P value < 0.05 was considered signiﬁcant. The data were
analyzed using the Statistical Package for the Social Sciences
(SPSS, version 15.0; SPSS, Inc., Chicago, IL, USA).
3. Results
One month follow up was completed for all patients. During
this month, 9 patients died (non survivors), and death is mostly
related to pulmonary embolism. The patients were accordingly
classiﬁed into survivors and non survivors.
3.1. Baseline patient characteristics
Table 2 states the basal patient characteristics. Thirty-two
patients were included in the study, 23 (71.8%) of them were)
seen in the left main pulmonary artery, QS > 18. (b) RV/LV ratio
ux in the inferior vena cava and hepatic veins. The patient died on
(a) (b)
(c)
Fig. 2 CTPA of a male patient aged 55 years. (a, b) Thrombus seen in the inferior lobar artery, Qanadli score <18. (c) RV/LV
ratio = 1, with normal interventricular septum. Small area of pulmonary infarction in the right lower lobe. The patient was a survivor.
Table 2 Patient characteristics of the study.
Parameters Survivors (n= 23) Non survivors (n= 9) P value
Age 55.6 ± 9.5 58 ± 8.7 0.214
Male gender (%) 15 (65.2) 6 (66.6) 0.651
Smoking (%) 10 (43.4) 7 (77.7) 0.01*
Hypertension (%) 15 (65.2) 6 (66.6) 0.651
Diabetes (%) 7 (30.4) 3 (33.3) 0.55
CAD (%) 3 (13.04) 5 (55.5%) 0.001*
S creatinine (%) 0.9 ± 0.8 1.2 ± 1.4 0.61
* Signiﬁcant <0.05.
Table 3 Relation ship between Qanadli score and patient
outcome in the current study.
Q score Survivors (n= 23) Non survivors (n= 9) P value
QS < 18 18 3
0.05
QS > 18 5 6
1092 M.M. Hefeda, M.M. Elmasryclassiﬁed as survivors, and the other nine (28.1%) patients
died within the ﬁrst month (non survivors). There was no
signiﬁcant difference between the two groups as regards
age, gender, presence of hypertension, diabetes and the serum
creatinine level. The presence of coronary artery disease was
signiﬁcantly higher in non survivors than survivors. Also,
smoking was signiﬁcantly higher in non survivors than
survivors.3.2. Clot burden
There was a positive, but weak correlation between the Qana-
dli score and the short term survival. Of 11 patients with
QS > 18, 6 died within 30 days and 5 survived. On the other
hand, of 21 patients with QS < 18, only 3 died within 30 days.
(Table 3) (Figs. 3 and 4).
3.3. Right heart dysfunction parameters
In the current study, right heart dysfunction parameters were
studied (Table 4). There was a statistically signiﬁcant relation-
ship between the RV/LV ratio and PE-related mortality, with a
P value < 0.001. Also, the shape of the interventricular septum
Prediction of short term outcome of pulmonary embolism 1093shows good correlation with outcome, 7/9 of the patients died
during the 30 day period had abnormal septum. The PA/AO
diameter ratio, SVC diameter and azygous vein diameter show
no statistically signiﬁcant difference between survivors and non
survivors.
The degree of reﬂux into the inferior vena cava was classi-
ﬁed as mild–moderate (grade I–III), and signiﬁcant (grade
IV–VI) There was a good correlation between degree of reﬂux
and PE outcome (P< 0.001) (Table 4) (Fig. 1d).
3.4. Correlation between clot burden and signs of right
ventricular dysfunction
RV/LV ratio was signiﬁcantly higher (P= 0.002) in patients
with QS > 18. The PA/AO ratio, SVC, AV were similar in sur-
vivor and non survivor groups. The Interventricular septal
abnormality was greater in patients with QS > 18 points, P
value 0.05 (Table 5).Fig. 3 CTPA of a female patient aged 42 years. (a–c) Large thrombi
Dilated main pulmonary artery relative to the ascending aorta is see
septum. (c) No IVC reﬂux. The patient was a non survivor, died on t3.5. Ratio of pulmonary artery enhancement to descending aorta
enhancement
In the current study, there was no signiﬁcant relation between
the degree of enhancement in the descending aorta and the pul-
monary artery (Table 6).
The IVC reﬂux had sensitivity 66.6%, speciﬁcity 79.2% in
prediction of short term mortality. The RV/LV ratio had sen-
sitivity 77.7% and speciﬁcity 65.2% (Table 7).
4. Discussion
In the current study, there was no signiﬁcant difference in age,
sex, hypertension, diabetes mellitus, and renal function among
survivor and non survivor groups. The presence of coronary
artery disease and previous history of smoking were signiﬁ-
cantly higher among non survivors than survivors.seen in the left and right pulmonary arteries. Qanadli score >18.




Fig. 4 CTPA of a female survivor patient aged 55 year, with thrombus in the right inferior lobar artery, Qanadli score <18, wedge
shaped infarction in the right lower lobe, RV/L V ratio <1, normal interventricular septum and no IVC reﬂux.
Table 4 Relation between right ventricular dysfunction parameters and patient outcome in the study group.
Parameters Survivors (n= 23) Non survivors (n= 9) P value
RV/LV
>1.2 8 (34.7) 7 (77.7) <0.001*
<1.2 15 (65.2) 2 (22.2)
Interventricular septum
Normal 12 (47.8) 2 (22.2) 0.01*
Flattened 11 (39.1) 5 (55.5)
Bowed To left 0 2 (22.2)
PA/AO ratio
>1.0 10 (43.4) 5 (55.5) 0.42
<1.0 13 (56.5) 4 (44.4)
SVC diameter** 17.2 ± 5.2 18.4 ± 4.9 0.61
Azygous vein** 9.1 ± 3.8 9.8 ± 3.2 0.66
IVC reﬂux
Grades 1–3 19 (82.6) 3 (33.3)
Grades 4–6 4 (17.4) 6 (66.6) <0.001*
* Signiﬁcant <0.05.
** Value = mean ± standard deviation. RV/LV: right ventricle/left ventricle ratio; PA/AO: pulmonary artery/aorta ratio; SVC: superior vena
cava; IVC: inferior vena cava.
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direct visualization of the clot within the pulmonary artery is
an accurate method of diagnosing PE. Also, determination
of the degree of vascular obstruction helps in the stratiﬁcation
of patient risk and enables treatment monitoring (10,19).
There are various systems described in the literature to
assess the pulmonary tree and calculate clot burden scores
(8–11). Our study used the Qanadli score, as it was considered
the easiest to calculate.The literature shows mixed results in the usefulness of the
PA obstruction index as a predictor of RVD and mortality.
Qanadli et al. found that a CT obstruction score of 40% or
greater correlates well with RV dilatation (10). Later, Van
der Meer et al., reported an 11.2-fold increased risk of short
term mortality for patients with an obstruction index of 40%
or higher (7). In a study that included 48 patients, Bazeed
et al. reported a signiﬁcant difference in the PA obstruction
index between survivors and non-survivors (P value < 0.001)
Table 5 Correlation between the QS and right ventricular dysfunction parameters.
QS < 18 (n= 21) QS > 18 (n= 11) P
RV/LV ratio 1.08 (±0.47) 1.58 (±0.33) 0.002*
PA/AO ratio 0.85 (±0.16) 0.98 (±0.17) 0.215
SVC diameter (mm) 18.3 (±4.9) 19.4 (±3.8) 0.143
AV diameter (mm) 9.6 (±2.67) 10.1 (±2.2) 0.41
IVS abnormality (%) 57.1% 72.7% 0.005*
* Signiﬁcant <0.05. Value = mean ± standard deviation. QS: Qanadli score; RV/LV: right ventricle/left ventricle ratio; PA/AO: pulmonary
artery/aorta ratio; SVC: superior vena cava; AV: azygous vein; IVS: interventricular septum.
Table 6 Relationship between ratio between pulmonary artery enhancement and aortic enhancement and patient outcome in the
current study.
Survivors (n= 23) Non survivors (n= 9) P value
DAE/MPAE 0.64 ± 0.27 0.55 ± 0.18 0.15
*Signiﬁcant <0.05. DAE: descending aortic enhancement; MPAE: main pulmonary artery enhancement. Mean ± standard deviation.
Table 7 Statistical analysis of different parameters for predicting short-term death. Due to PE.
Parameters Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
QS score 66.6 78.2 54.5 85.7
RV/LV 77.7 65.2 46.6 88.2
Interventricular septum 77.7 52.1 38.8 100
PA/AO ratio 55.5 56.2 33.3 76.4
IVC reﬂux 66.6 79.1 60 86.3
QS: Qanadli score; RV/LV: right ventricle/left ventricle ratio; PA/AO: pulmonary artery/aorta ratio; IVC: inferior vena cava.
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obstruction index showing signiﬁcant risk factors for mortality
(P< 0.001). Another study revealed a higher obstruction
index in patients who had poor prognosis (22). Also, Huang
and Fei (23), found that the severity of the obstruction index
using CTPA signiﬁcantly correlated with the blood gas values.
In the current study; QS showed positive correlation with short
term mortality (P value = 0.05, sensitivity = 66.6% and spec-
iﬁcity = 78.2%). On the other hand, Ghaye et al. (24), Araoz
et al. (16) and Collomb et al. (17) found PA clot load scores to
be a poor predictor of mortality in patients with acute PE.
While PA clot load scores can be an indicator of the severity
of the current episode of PE or treatment effectiveness, it seems
that they cannot be used as a predictor of RV failure and death
of the patient (25) (Fig. 5).
The marked controversy in the literature may be explained
by the fact that pulmonary vascular resistance is not only
related to mechanical obstruction by the intravascular clot
load but can be further increased by the release of vasoactive
agents; reﬂex PA vasoconstriction and systemic arterial hyp-
oxemia occurring during PE (26–28). Furthermore, PA clot
load scores do not take into account clots located in small
peripheral PAs (29). Finally, PA clot load scores do not take
into account possible unresolved previous episodes of PE,emphysema, or other restrictive pleuro-parenchymal disease
(17).
Right ventricular dysfunction (RVD) is the most common
cause of short-term mortality in patients with acute pulmonary
embolism (PE) (30). The pathophysiology of RVD in PE is
thought to be due to a sharp increase in the right ventricular
(RV) after-load caused by mechanical pulmonary arterial
obstruction and pulmonary vasoconstriction (31). Previous
studies have reported that RV failure, is a more accurate indi-
cator of the severity of PE than the degree of obstruction at
angiography or scintigraphy (32,33).
Several studies have proposed an increased RVD/LVD
ratio as a predictor of short-term mortality after PE
(17,24,34–36). Lim et al. (37) found a RVD/LVD ratio of
greater than 1 measured on axial sections indicative of RV
strain at pulmonary CTA, whereas others have proposed a
threshold ranging 1–1.5 (16,17,38,39). In the current study,
we used a threshold of 1.2, with a highly signiﬁcant difference
(P 6 0.001) between survivors and non survivors. However,
other previous studies failed to prove any association between
mortality and increased RV/LV ratio (16,35,40). The reason
for this discrepancy in the literature could be partially due to
the difference in the RV/LV ratio measurements (e.g., standard
axial view of the heart versus reconstructed four-chamber
Fig. 5 CTPA of a male patient aged 51 years. Large thrombus seen in the right main pulmonary artery and inferior pulmonary arteries,
Qanadli score <18. The patient was a non survivor, died on the ﬁrst day.
1096 M.M. Hefeda, M.M. Elmasryview) and diversity of CT acquisition (different CT scanner
geometry).
The other important parameter for predicting short term
mortality in this study was reﬂux of the dye in the inferior vena
cava, which associated with poor outcome. Kang et al. (41) in
a study that included 260 patients found that the inferior vena
cava contrast reﬂux associated with poor outcome (HR: 2.57;
P= 0.001). Reﬂux of contrast medium into the IVC is an indi-
rect sign of tricuspid valve insufﬁciency, frequently observed in
right heart failure (33). Nevertheless, Collomb et al. (17) on the
other hand, found this sign not differentiate patients with
severe PE from patients with non-severe PE, although the
prevalence of IVC reﬂux in their study was somewhat smaller
(12%).
The interventricular septum, which normally bows toward
the RV, may shift toward the LV related to increased right
heart pressure with severe pulmonary arterial obstruction
(42). Septal bowing is not speciﬁc for acute PE and can be
found in numerous disorders resulting in increased pulmonary
artery pressure. In the literature, controversy predominates
regarding the signiﬁcance of interventricular septum abnormal-
ity in prediction of short term mortality. On the one hand, Ara-
oz et al. (35) and Collomb et al. (17) reported that ventricular
septal bowing strongly predicted admission to the ICU. On
the other hand, Araoz et al. (16) and Van der Meer et al. (7)
did not ﬁnd this sign to be predictive of death from acute PE.
In the current study, there was a positive correlation
between the IVS abnormality and the short term mortality
(P= 0.01). Ventricular septal bowing detected with CT may
be a predictor, but it may not be a very powerful one (35).
No signiﬁcant association between the diameters of the
superior vena cava, the azygos vein diameters and short-term
mortality in the current study, in agreement with a recent
report by Furlan et al. (43). However, two other studies
reported that the mean diameter of the azygos vein and supe-
rior cava vena was higher in non survivors than in survivors
(24,34).
In accordancewith the previous report by Park et al. (44), the
ratio of the descending aorta enhancement to main pulmonary
artery enhancement showed no signiﬁcant difference between
survivors and non survivors, and we are in agreement with the
previous report that the ratio of descending aortic enhancementto main pulmonary artery enhancement proposed by the
authors may not be likely to predict the prognosis.
This study has potential limitations, the number of cases is
relatively limited because we excluded from the study, patients
we could not follow up for full 30 days (11 patients), patients
with renal failure (2 patients), patients with concomitant myo-
cardial infarction (2 patients) and patients with cerebral infarc-
tion (3 patients). Also, we did not correlate the results of CTA
with echocardiographic ﬁndings. Another important limitation
is that we did not use ECG gated CTPA. Non-ECG-gated pul-
monary CTA is inevitably inaccurate for measuring the ven-
tricular chamber size because the images are acquired in
different phases of the cardiac cycle. Also Inter-observer vari-
ation was not included in the study.
5. Conclusion
CTPA ﬁndings that may predict the short term mortality are
the high grades of inferior vena cava reﬂux, RV/LV diameter
ratio more than 1.2, and clot burden >18 according to the
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